sorafenib
Sorafenib is a drug used to treat Hepatocellular Carcinoma, Acute Myeloid Leukemia, Liver Cancer, and other conditions. Sorafenib is being actively studied in 56 studies and prior, has been studied in 171.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
M.D. Anderson Cancer Center | Samsung Medical Center | Shi Ming |
Sun Yat-sen University | Cancer Center Sun Yat-sen University | Qifa Liu |
SCRI Development Innovations, LLC | University of Texas MD Anderson Cancer Center | Guohong Han |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
Terminated
- Carcinoma, Hepatocellular
- Proton Beam Radiotherapy
- Sorafenib
- Loma Linda, CaliforniaLoma Linda University Medical Center
2021-09-21
Sep 21, 2021P
Completed
- HepatoCellular Carcinoma
- Portal Vein Thrombosis
- HAIC
- Sorafenib
- Beijing, Beijing, ChinaPeking University Cancer Hospital
2021-10-08
Oct 8, 2021T
Active, not recruiting
- Differentiated Thyroid Cancer
- Everolimus
- Sorafenib
- Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
2021-10-18
Oct 18, 2021M
Recruiting
- Hepatocellular Carcinoma
- +2 more
- MTL-CEBPA
- Sorafenib
- Duarte, California
- +1 more
2022-02-20
Feb 20, 2022B
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Sorafenib
- (no location specified)
2021-11-02
Nov 2, 2021Y
Completed
- Hepatocellular Carcinoma
- Hepatoma
- sorafenib
- LC Bead-TACE
- Baltimore, MarylandThe Johns Hopkins Hospital
2021-10-15
Oct 15, 2021N
Completed
- Brain Tumor
- +2 more
- everolimus
- sorafenib
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022N
Completed
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Bone Marrow Transplantation
- +2 more
- Baltimore, Maryland
- +1 more
2021-05-27
May 27, 2021M
Completed
- Advanced Adult Hepatocellular Carcinoma
- +10 more
- Laboratory Biomarker Analysis
- +4 more
- Houston, TexasM D Anderson Cancer Center
2021-12-01
Dec 1, 2021W
Recruiting
- Hepatocellular Cancer
- hepatic resection
- Sorafenib
- Shanghai, ChinaEastern Hepatobiliary Surgery Hospital
2021-04-08
Apr 8, 2021H
Recruiting
- Pancreas Cancer
- Vemurafenib
- Sorafenib
- Scottsdale, ArizonaHonorHealth Research Institute
2021-10-28
Oct 28, 2021S
Completed
- Hepatocellular Carcinoma
- HAIC
- Sorafenib
- Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
2021-11-16
Nov 16, 2021H
Completed
- Hepatocellular Cancer
- Liver Cancer
- Trametinib
- Sorafenib
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-06-09
Jun 9, 2021S
E
Completed
- Hepatocellular Carcinoma
- Sorafenib
- Tucson, Arizona
- +23 more
2021-04-16
Apr 16, 2021C
Recruiting
- Radiotherapy
- +3 more
- Radiotherapy plus Toripalimab
- Sorafenib
- Beijing, Beijing, ChinaBo Chen
2021-03-06
Mar 6, 2021B
Enrolling by invitation
- Carcinoma, Hepatocellular
- Portal Vein Tumor Thrombus
- Lenvatinib Pill
- +2 more
- Beijing, Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
2021-07-19
Jul 19, 2021T
Active, not recruiting
- Hepatocellular Carcinoma
- Advanced Cancer
- Sorafenib
- CVM-1118
- Charleston, South Carolina
- +2 more
2022-01-25
Jan 25, 2022S
Recruiting
- Hepatocellular Carcinoma
- Toripalimab
- Sorafenib
- Shanghai, ChinaZhongshan Hospital
2021-06-14
Jun 14, 2021I
Recruiting
- Hepatocellular Carcinoma
- IBI310
- +2 more
- Shanghai, Shanghai, ChinaFudan Universtiy Zhongshan Hospital
2021-11-26
Nov 26, 2021F
Active, not recruiting
- Hepatocellular Carcinoma
- Recombinant Human Adenovirus Type 5 injection
- Sorafenib
- Xi'an, Shaanxi, China
- +3 more
2022-01-25
Jan 25, 2022U
Completed
- Hepatocellular Carcinoma
- Sorafenib
- Toronto, Ontario, CanadaUniversity Health Network
2021-10-04
Oct 4, 2021M
Active, not recruiting
- Hepatocellular Carcinoma
- Sorafenib
- Doxorubicin
- Basking Ridge, New Jersey
- +5 more
2021-05-04
May 4, 2021M
Completed
- Breast Cancer
- Brain Metastases
- Whole Brain Radiotherapy (WBRT)
- Sorafenib
- Basking Ridge, New Jersey
- +5 more
2022-03-04
Mar 4, 2022S
Completed
- Advanced Solid Tumors
- Hepatocellular Carcinoma
- BBI503
- Sorafenib
- Chiba, Etc., Japan5 Sites
2021-03-23
Mar 23, 2021